Company Arsanis Inc Nasdaq
Equities
US0428731097
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 30/06/14 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 31/08/18 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 31/12/16 |
Chief Tech/Sci/R&D Officer | - | 31/07/23 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/11/20 |
Murray Stewart
BRD | Director/Board Member | 63 | 28/03/19 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | 60 | 25/11/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 30/06/18 |
David McGirr
BRD | Director/Board Member | 69 | 31/08/17 |
Paula Ragan
FOU | Founder | 54 | 30/06/14 |
Gary Bridger
BRD | Director/Board Member | 61 | 30/09/18 |
Alison Lawton
BRD | Director/Board Member | 62 | 04/10/20 |
Bill Aliski
BRD | Director/Board Member | 75 | 17/09/19 |
Director/Board Member | 62 | 13/10/21 | |
Murray Stewart
BRD | Director/Board Member | 63 | 28/03/19 |
R. Woods
BRD | Director/Board Member | 56 | 31/08/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,937,781 | 162,460,401 ( 96.74 %) | 0 | 96.74 % |
Company contact information
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.com![address Arsanis Inc](https://cdn.zonebourse.com/static/address/38702344.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+16.44% | 122B | |
+18.94% | 113B | |
+18.52% | 26.22B | |
-25.37% | 19.01B | |
-19.86% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |